Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date Filed: May 3, 2018
Reporting Period: First Quarter ended March 31, 2018
Context: This filing announces the Company's first-quarter 2018 results via a Press Release furnished as Exhibit 99.1, with corresponding financial figures in Exhibit 99.2.
Key Financial Metrics
The filing text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached Exhibits (99.1 and 99.2).
Non-GAAP Measures Discussed: The Company utilizes the following non-GAAP measures to supplement IFRS results:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
- Results presented in constant currency
Note: Specific values for these metrics are not provided in the filing text itself.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It states that non-GAAP measures are included to provide consistency and comparability to prior periods, but the actual comparative figures are contained in the attached exhibits.
Guidance, Outlook, and Risks
Management Commentary: Management states that the non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures should not be used as a substitute for or considered superior to GAAP (IFRS) financial measures.
Reconciliation: Reconciliations of non-GAAP measures to the most comparable IFRS measures are included in the attached Press Release and Cash Flow Statement.
Legal Disclaimer: The attached exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2018 revenue and profit figures.
- Examine Exhibit 99.2 for detailed financial statements and cash flow data.
- Verify the reconciliation of non-GAAP measures (EBITDA, Free Cash Flow) to IFRS standards in the attached exhibits.
- Check for constant currency adjustments to understand organic growth versus currency impact.
- Confirm the specific debt and liquidity positions as they are not detailed in this cover letter.